Neonatal neutropenia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:37629
Who is this for?
Show terms as
17Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Neonatal neutropenia is a hematological condition characterized by an abnormally low number of neutrophils (a type of white blood cell essential for fighting bacterial and fungal infections) in newborn infants. Neutropenia in neonates is generally defined as an absolute neutrophil count (ANC) below 1,000–1,500 cells per microliter of blood, though reference ranges vary depending on gestational age and postnatal age. The condition primarily affects the immune system, leaving affected neonates vulnerable to serious and potentially life-threatening bacterial and fungal infections. Clinical manifestations may include fever, skin infections, omphalitis (infection of the umbilical stump), pneumonia, sepsis, and other localized or systemic infections. Neonatal neutropenia can arise from multiple etiologies. It may be alloimmune (caused by maternal antibodies directed against fetal neutrophil antigens, analogous to hemolytic disease of the newborn), autoimmune (associated with maternal autoimmune conditions), or secondary to maternal conditions such as pregnancy-induced hypertension or preeclampsia. It can also occur in the context of congenital or genetic forms of neutropenia, infections (bacterial or viral), necrotizing enterocolitis, or bone marrow suppression. Premature and low-birth-weight infants are particularly susceptible. Management depends on the underlying cause and severity. In many cases, neonatal neutropenia is transient and resolves spontaneously within days to weeks as the infant's bone marrow matures or as maternal antibodies are cleared. For infants with severe neutropenia and active or recurrent infections, treatment may include antibiotics, antifungal agents, and in some cases recombinant granulocyte colony-stimulating factor (G-CSF) to stimulate neutrophil production. Intravenous immunoglobulin (IVIG) may be considered in alloimmune cases. Close monitoring of blood counts and vigilant infection surveillance are essential components of care.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Neonatal neutropenia.

View clinical trials →

No actively recruiting trials found for Neonatal neutropenia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Neonatal neutropenia community →

Specialists

17 foundView all specialists →
PM
Paul Orchard, MD
MINNEAPOLIS, MN
Specialist
PI on 15 active trials
MM
Matthew M Hsieh, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 4 active trials
MP
Marcin Wlodarski, MD, PhD
MEMPHIS, TN
Specialist
PI on 1 active trial
DM
David T. Teachey, MD
PHILADELPHIA, PA
Specialist
PI on 1 active trial
BM
Biljana Horn, MD
SAN FRANCISCO, CA
Specialist
PI on 2 active trials
CP
Chi Hornik, PharmD
DURHAM, NC
Specialist
PI on 1 active trial
LS
Laurent Servais
Specialist
PI on 1 active trial28 Neonatal neutropenia publications
SM
Shahin Lockman, MD
BOSTON, MA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Neonatal neutropenia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Neonatal neutropeniaForum →

No community posts yet. Be the first to share your experience with Neonatal neutropenia.

Start the conversation →

Latest news about Neonatal neutropenia

No recent news articles for Neonatal neutropenia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Neonatal neutropenia

What is Neonatal neutropenia?

Neonatal neutropenia is a hematological condition characterized by an abnormally low number of neutrophils (a type of white blood cell essential for fighting bacterial and fungal infections) in newborn infants. Neutropenia in neonates is generally defined as an absolute neutrophil count (ANC) below 1,000–1,500 cells per microliter of blood, though reference ranges vary depending on gestational age and postnatal age. The condition primarily affects the immune system, leaving affected neonates vulnerable to serious and potentially life-threatening bacterial and fungal infections. Clinical manife

At what age does Neonatal neutropenia typically begin?

Typical onset of Neonatal neutropenia is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Neonatal neutropenia?

17 specialists and care centers treating Neonatal neutropenia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.